# Multiple Inhibitory Mechanisms of DS16570511 Targeting Mitochondrial Calcium Uptake: Insights from Biochemical Analysis of Rat Liver Mitochondria

## TL;DR

This study reveals that DS16570511 inhibits mitochondrial calcium uptake through multiple mechanisms, including effects on the MCU and respiratory chain complexes.

## Contribution

The discovery that DS16570511 inhibits respiratory chain complex II and MCU expands its known mechanisms of action.

## Key findings

- DS16570511 inhibits MCU, respiratory chain complexes, and FoF1-ATPase/adenine nucleotide translocator.
- The carboxyl group of DS16570511 is critical for its inhibitory effects on mitochondrial calcium uptake.
- The drug shows variable potency in inhibiting different mitochondrial processes.

## Abstract

Mitochondrial calcium (Ca2+) uptake plays a key role in mitochondrial physiology and disease development. This process is regulated by the mitochondrial calcium uniporter (MCU) complex. DS16570511 is a membrane-permeable drug that inhibits mitochondrial Ca2+ uptake, although its inhibitory mechanisms remain unclear. In this study, we evaluated the effects of DS16570511 on various mitochondrial functions through biochemical analyses. We found that DS16570511 affects multiple mitochondrial functions and exhibits variable potency in inhibiting individual processes. Specifically, DS16570511 not only inhibits MCU, its initially reported target, but also respiratory chain complexes and FoF1-adenosine triphosphatase/adenine nucleotide translocator, particularly respiratory chain complex II. Furthermore, the carboxyl group at the molecular terminus of DS16570511 plays a critical role in its inhibitory effects on mitochondrial Ca2+ uptake through respiratory chain complex II inhibition. These findings enhance our understanding of the mechanisms by which DS16570511 inhibits mitochondrial Ca2+ uptake and provide valuable insights for the clinical application of mitochondrial Ca2+ uptake inhibitors.